In:
Complex Issues of Cardiovascular Diseases, NII KPSSZ, Vol. 10, No. 3 ( 2021-09-25), p. 121-129
Abstract:
At the online meeting of experts held on April 24, 2021, the results of the international multicenter trial EMPEROR-Reduced were considered. Taking into account the beneficial cardiovascular and renal outcomes in patients with chronic heart failure and reduced left ventricular ejection fraction ( 〈 40%), and improvement in patient survival rates, a number of proposals and recommendations for widespread implementation of the trial results into practice of treating patients with chronic heart failure were adopted.
Type of Medium:
Online Resource
ISSN:
2587-9537
,
2306-1278
DOI:
10.17802/2306-1278-2021-10-3-121-129
Language:
Unknown
Publisher:
NII KPSSZ
Publication Date:
2021
Permalink